首页|期刊导航|国际肝胆健康（英文）|Efficacy and safety of PD-1 inhibitors for advanced intrahepatic cholangiocarcinoma with or without MAFLD

Efficacy and safety of PD-1 inhibitors for advanced intrahepatic cholangiocarcinoma with or without MAFLD

Teng Long Zhenyun Yang Weijie Wu Minshan Chen Dandan Hu

国际肝胆健康（英文）Issue(2)：64-72,9.

国际肝胆健康（英文）Issue(2)：64-72,9.DOI:10.1016/j.iliver.2025.100169

Efficacy and safety of PD-1 inhibitors for advanced intrahepatic cholangiocarcinoma with or without MAFLD

Teng Long ¹Zhenyun Yang ²Weijie Wu ³Minshan Chen ¹Dandan Hu²

作者信息

1. Department of Liver Surgery,Sun Yat-sen University Cancer Center,Guangzhou 510000,Guangdong,China
2. Collaborative Innovation Center for Cancer Medicine,State Key Laboratory of Oncology in South China,Sun Yat-Sen University Cancer Center,Guangzhou 510000,Guangdong,China
3. Guangdong Provincial Clinical Research Center for Cancer,Sun Yat-Sen University Cancer Center,Guangzhou 510000,Guangdong,China
折叠

摘要

关键词

Intrahepatic cholangiocarcinoma/Programmed cell death protein-1 inhibitor/Metabolic dysfunction-associated fatty liver disease/Tumor response/Adverse events

Key words

Intrahepatic cholangiocarcinoma/Programmed cell death protein-1 inhibitor/Metabolic dysfunction-associated fatty liver disease/Tumor response/Adverse events

引用本文复制引用

Teng Long,Zhenyun Yang,Weijie Wu,Minshan Chen,Dandan Hu..Efficacy and safety of PD-1 inhibitors for advanced intrahepatic cholangiocarcinoma with or without MAFLD[J].国际肝胆健康（英文）,2025,(2):64-72,9.

基金项目

This work was supported by grants from the National Natural Science Foundation of China(No:82472801,82103566)and,Basic and Applied Basic Research of Guangzhou Science and Technology Plan Project(No:2023A04J2123). （No:82472801,82103566）

国际肝胆健康（英文）

访问量1

下载量0

段落导航